Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Alvarez

Showing results (591-600 of 644) with videos related to

Pageof 65
Sort By:
Molecular Cancer Therapeutics|April 19, 2017
Oncogenic Characterization and Pharmacologic Sensitivity of Activating Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations to the Selective FGFR Inhibitor ErdafitinibJayaprakash D Karkera, Gabriela Martinez Cardona, Katherine Bell, et al.
Anales Espanoles De Pediatria|November 1, 1987
[Early diagnosis of anemia. Round table]J Navarro González, J J Cardesa García, J M García-Cubillana y de la Cruz, et al.
Gynecologic Oncology|January 29, 2002
Conservative management of stage I endometrial carcinoma after surgical stagingJ Michael Straughn, Warner K Huh, F Joseph Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicityTyler O Kirby, Angel Rivera, Daniel Rein, et al.
Gynecologic Oncology|August 29, 2017
FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White PaperThomas J Herzog, Gwynn Ison, Ronald D Alvarez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2010
A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseasesKristopher J Kimball, Meredith A Preuss, Mack N Barnes, et al.
Natural Product Communications|August 14, 2014
Dialyzable leukocyte extracts activate TLR-2 on monocytesUriel García-Hernández, Frank H Robledo-Avila, Violeta D Alvarez-Jiménez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 6, 2012
A tumor-stroma targeted oncolytic adenovirus replicated in human ovary cancer samples and inhibited growth of disseminated solid tumors in miceM Veronica Lopez, Angel A Rivera, Diego L Viale, et al.
Gynecologic Oncology|April 26, 2003
Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapyJ Michael Straughn, Warner K Huh, James W Orr, et al.
Cancer Gene Therapy|March 16, 2004
Transcriptional targeting of tumors with a novel tumor-specific survivin promoterZeng B Zhu, Sharmila K Makhija, Baogen Lu, et al.
Pageof 65

Showing results (591-600 of 644) with videos related to

Sort By:
Pageof 65
Molecular Cancer Therapeutics|April 19, 2017
Oncogenic Characterization and Pharmacologic Sensitivity of Activating Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations to the Selective FGFR Inhibitor ErdafitinibJayaprakash D Karkera, Gabriela Martinez Cardona, Katherine Bell, et al.
Anales Espanoles De Pediatria|November 1, 1987
[Early diagnosis of anemia. Round table]J Navarro González, J J Cardesa García, J M García-Cubillana y de la Cruz, et al.
Gynecologic Oncology|January 29, 2002
Conservative management of stage I endometrial carcinoma after surgical stagingJ Michael Straughn, Warner K Huh, F Joseph Kelly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicityTyler O Kirby, Angel Rivera, Daniel Rein, et al.
Gynecologic Oncology|August 29, 2017
FDA ovarian cancer clinical trial endpoints workshop: A Society of Gynecologic Oncology White PaperThomas J Herzog, Gwynn Ison, Ronald D Alvarez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2010
A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseasesKristopher J Kimball, Meredith A Preuss, Mack N Barnes, et al.
Natural Product Communications|August 14, 2014
Dialyzable leukocyte extracts activate TLR-2 on monocytesUriel García-Hernández, Frank H Robledo-Avila, Violeta D Alvarez-Jiménez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 6, 2012
A tumor-stroma targeted oncolytic adenovirus replicated in human ovary cancer samples and inhibited growth of disseminated solid tumors in miceM Veronica Lopez, Angel A Rivera, Diego L Viale, et al.
Gynecologic Oncology|April 26, 2003
Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapyJ Michael Straughn, Warner K Huh, James W Orr, et al.
Cancer Gene Therapy|March 16, 2004
Transcriptional targeting of tumors with a novel tumor-specific survivin promoterZeng B Zhu, Sharmila K Makhija, Baogen Lu, et al.
Pageof 65